Evidence map›Paper›PMID 36559132›Full record

ArticlePharmaceutics2022

Photodynamic Therapy with Nebulized Nanocurcumin on A549 Cells, Model Vessels, Macrophages and Beyond.

María Julia Altube, Ezequiel Nicolás Caputo, Martín Nicolás Rivero, María Laura Gutiérrez, Eder Lilia Romero

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

María Julia AltubeNanomedicine Research and Development Centre (NARD), Science and Technology Department, National University of Quilmes (UNQ), Roque Saenz Peña 352, Bernal B1876, Argentina.ORCID 0000-0002-5902-327X
Ezequiel Nicolás CaputoNanomedicine Research and Development Centre (NARD), Science and Technology Department, National University of Quilmes (UNQ), Roque Saenz Peña 352, Bernal B1876, Argentina.ORCID 0000-0002-6236-4083
Martín Nicolás RiveroInstitute of Pharmacology, University of Buenos Aires (UBA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Paraguay 2155 piso 9, Buenos Aires C1121, Argentina.
María Laura GutiérrezInstitute of Pharmacology, University of Buenos Aires (UBA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Paraguay 2155 piso 9, Buenos Aires C1121, Argentina.ORCID 0000-0003-4000-7816
Eder Lilia RomeroNanomedicine Research and Development Centre (NARD), Science and Technology Department, National University of Quilmes (UNQ), Roque Saenz Peña 352, Bernal B1876, Argentina.
National University of Quilmes · ARConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

National University of Quilmes Programa de Nanomedicinas-2
6 · The paper itself

Abstract

This study aimed to determine the damage mechanisms caused by naturally targeted nanoarchaeosomes made of diether lipids from

Indexed as

A549curcuminmacrophagesnanoarchaeosomesPDTvessels

Identifiers

PMID36559132
PMCPMC9781346
OpenAlexW4311001936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.